BIOLIFE SOLUTIONS INC's ticker is BLFS and the CUSIP is 09062W204. A total of 153 filers reported holding BIOLIFE SOLUTIONS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,352,737 | +582.8% | 242,776 | +1024.0% | 0.03% | +466.7% |
Q3 2022 | $491,000 | +63.1% | 21,600 | -0.9% | 0.01% | +100.0% |
Q2 2022 | $301,000 | -85.9% | 21,800 | -62.0% | 0.00% | -81.2% |
Q4 2021 | $2,136,000 | -73.0% | 57,300 | -69.4% | 0.02% | -72.9% |
Q3 2021 | $7,920,000 | -3.9% | 187,156 | +1.1% | 0.06% | +3.5% |
Q2 2021 | $8,243,000 | -24.1% | 185,196 | -38.6% | 0.06% | -21.9% |
Q1 2021 | $10,854,000 | -67.8% | 301,496 | -64.3% | 0.07% | -73.8% |
Q4 2020 | $33,712,000 | +37.8% | 845,116 | 0.0% | 0.28% | +5.7% |
Q3 2020 | $24,458,000 | +120.1% | 845,116 | +24.4% | 0.26% | +116.4% |
Q2 2020 | $11,112,000 | +143.3% | 679,616 | +41.4% | 0.12% | +96.8% |
Q1 2020 | $4,567,000 | +27.9% | 480,716 | +117.8% | 0.06% | +93.8% |
Q4 2019 | $3,571,000 | +9.2% | 220,716 | +12.2% | 0.03% | +6.7% |
Q3 2019 | $3,269,000 | +3.3% | 196,655 | +5.4% | 0.03% | +3.4% |
Q2 2019 | $3,164,000 | – | 186,655 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 7,566,292 | $171,982,000 | 7.71% |
Gagnon Advisors, LLC | 205,968 | $4,682,000 | 2.16% |
Ranger Investment Management | 1,300,407 | $29,558,000 | 1.87% |
GAGNON SECURITIES LLC | 379,506 | $8,626,000 | 1.41% |
Zweig-DiMenna Associates LLC | 376,550 | $8,559,000 | 1.14% |
Meros Investment Management, LP | 48,504 | $1,102,000 | 0.87% |
Mesirow Financial Investment Management, Inc. | 10,526 | $239,000 | 0.81% |
Penbrook Management LLC | 48,615 | $1,105,000 | 0.72% |
MOODY ALDRICH PARTNERS LLC | 220,680 | $5,016,000 | 0.70% |
GENEVA CAPITAL MANAGEMENT LLC | 1,456,656 | $33,110,000 | 0.64% |